Allergan trims off fat-busting portfolio to Apollo
This article was originally published in Clinica
Executive Summary
Allergan has found a buyer for its underperforming obesity device business, nearly a year after putting it on the block. Austin, Texas-based Apollo EndoSurgery has definitively agreed to acquire the division, responsible for manufacturing and selling Allergan’s Lap-Band adjustable gastric band system and the Orbera intragastric balloon system, for up to $110m. The final consideration comprises a $75m upfront cash payment, a $15m stake in Allergan, and up to $20m in milestone payments linked to regulatory and sales targets.
You may also be interested in...
Apollo And ReShape Swap Bariatric Devices
Apollo Endosurgery sold its surgical product line, including the Lap-Band adjustable gastric banding system and other accessories for laparoscopic bariatric surgery, to ReShape Lifesciences for $17m plus other considerations, including the ReShape endoscopic balloon, the companies announced Dec. 18. The deal will allow Apollo to focus on endo-bariatric procedures while it gives ReShape an instant revenue stream and another product to sell to surgeons, its core customers.
Allergan Pays $4m In Two Lap-Band Settlements
Device manufacturer Allergan has agreed to pay $4m in two separate settlements involving the Lap-Band bariatric surgery device.
Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.